Back to Authors

Phipatanakul, Wanda

0000-0001-8639-0473

Mayo Clinic

Boston Children's Hospital

Citations 4

C34-10 Inflammatory Genes Are Downregulated in Induced Sputum of Corticosteroid Responders but Unchanged in Non-Responders
Zein, J G, Nixon, L, Kyriakidou, M, Hu, B, Castro, M, Denlinger, L C, Erzurum, S C, Fahy, J V, Gaston, B, Israel, E, Jarjour, N N, Levy, B D, Mauger, D, Moore, W C, Ortega, V E, Phipatanakul, W, Woodruff, P G, Wenzel, S E, Meyers, D A, Bleecker, E R, Zein, Joe , Denlinger, Loren C. , Fahy, John V. , Israel, Elliot , Levy, Bruce David , Phipatanakul, Wanda , Wenzel, Sally E. , Meyers, Deborah A.

American Journal of Respiratory and Critical Care Medicine | May 18, 2026 | Volume: 212 | Issue: Supplement_1 | Pages: No page available

10.1093/ajrccm/aamag162.595 Get It

Abstract Rationale We hypothesize that corticosteroid resistance causes uncontrolled inflammation and severe asthma. The genetic and molecular mechanisms underlying steroid responsiveness in asthma remain poorly understood (PMID28493293). This study aims to characterize transcriptomic profiles distinguishing steroid responders from steroid resistant asthma. Methods Longitudinal bulk RNA-seq of SARP3 sputum samples was analyzed before and after an “induced phenotype” with 40 mg triamcinolone acetonide (TCA) injection (PMID 27967215). Participants were classified as responders or non-responders based on whether their FEV₁ change after TCA exceeded the median. Paired differential gene expression analyses were performed separately for each group using limma and voom, with participant as a factor and adjustment for sputum cell count differentials. Z-scores were calculated to compare gene expression changes after TCA injection between responders and non-responders, and pathway enrichment was assessed using the fgsea package. Results Baseline demographics and clinical characteristics of 696 SARP3 asthma participants receiving TCA are shown in Table 1. The median [IQR] FEV1 change post-TCA was 1.81% [-2.16, 7.17]. Responders had higher baseline FEV1%, FEV1/FVC ratio, blood eosinophil counts, and sputum eosinophil percentages, but lower serum CRP levels. Steroid responsiveness was associated with asthma severity (Table 1). Among 154 participants with paired sputum RNA-seq data, 70 (45%) exhibited >1.81% improvement in FEV₁ and were classified as responders. Following TCA treatment, non-responders showed no significant changes in gene expression. In responders, 18 genes were upregulated and 203 downregulated. Downregulated genes were associated with Th2 immunity (IL13, IL1RL1, CCL17, SIGLEC8), IgE signaling (FCER1A, FCER2), epithelial barrier function and mucus production (MUC2, MUC7, ALOX15, TFF3), tissue remodeling and fibrosis (MMP10, TIMP3), ciliary function (DNAH5, CFAP43, FOXJ1), and airway hyperreactivity (HRH4, RAMP1). Key genes notably downregulated in responders compared to non-responders included IL13, CCL5, PTGDR2, FCER2, and CLEC10A. Pathway analysis revealed enhanced IL-10-mediated anti-inflammatory signaling, suppression of pro-inflammatory pathways (NF-κB, IL-1, Th1/Th2, asthma, arachidonic acid metabolism, chemokine, NOTCH4), and regulation of mitochondrial oxidative phosphorylation. Conclusions Steroid resistance impairs glucocorticoid-mediated suppression of pro-inflammatory pathways, including NF-κB, IL-1, and Th1/Th2 signaling. This persistent airway inflammation limits improvements in lung function and contributes to worse clinical outcomes, including increased airflow obstruction, and symptom burden. Glucocorticoid resistance in asthma may be driven by receptor dysfunction, airway inflammation, epigenetic changes, and environmental exposures resulting in persistent airway inflammation and remodeling. Elucidating the molecular mechanisms underlying steroid resistance is critical for developing personalized targeted therapies in asthma. This abstract is funded by: NIH-NHLBI - R01 HL161674 (PI: Joe Zein)
Self-Reported Resilience During the COVID-19 Pandemic
Ogungbe, Oluwabunmi , Wang, Tianyou , Meyer, Diane , Stukovsky, Karen Hinckley , Kucharska‐Newton, Anna , Gabriel, Kelley Pettee , Regan, Elizabeth A., Talavera, Gregory, Sims, Mario , Contreras, Jose Gutierrez, Kandula, Namratha R. , Lee, Joyce , Woodruff, Prescott G. , Ortega, Victor E. , Fretts, Amanda M. , Putcha, Nirupama , Hansel, Nadia N. , Oelsner, Elizabeth C. , Oelsner, Elizabeth C , Kucharska-Newton, Anna M , Lee, Joyce S , Balte, Pallavi , Slone, Sarah , Allen, Norrina B. , Buhr, Russell G. , Hirsch, Jana A. , Xanthakis, Vanessa , Isasi, Carmen R. , Daviglus, Martha , Perreira, Krista M. , Contreras, Jose Gutierrez, Howard, Virginia J. , Judd, Suzanne E. , Wenzel, Sally E. , Phipatanakul, Wanda , Post, Wendy S.

JAMA Network Open | July 16, 2025 | Volume: 8 | Issue: 7 | Pages: e2520360

10.1001/jamanetworkopen.2025.20360 Get It

ImportanceIdentifying factors associated with resilience during the COVID-19 pandemic can inform targeted interventions and resource allocation for groups disproportionately affected by systemic inequities.ObjectiveTo examine factors associated with self-reported resilience during the COVID-19 pandemic in racially and ethnically diverse, community-dwelling US adults.Design, Setting, and ParticipantsThis cross-sectional study was conducted as part of the Collaborative Cohort of Cohorts for COVID-19 Research (C4R) study, which assessed the associations of the pandemic with self-reported resilience of participants from 14 established US prospective cohorts since January 2021. This report includes participants who responded to the self-reported resilience question on C4R questionnaires. Data was initially analyzed from October 2023 to May 2024, with updated analyses performed from August 2024 to April 2025.ExposureRace and ethnicity, behavior factors, health conditions, and social determinants of health measurements accessed before and during the COVID-19 pandemic through cohort visits and C4R questionnaires.Main Outcomes and MeasuresSelf-reported resilience was collected via 1 question (from the Brief Resilience Scale) in C4R questionnaires, “I tend to bounce back quickly after hard times.” Participants who answered agree or strongly agree were classified as resilient, and those who reported neutral, disagree, or strongly disagree were classified as not resilient. Modified Poisson regression was performed to estimate prevalence ratios (PRs) and access multivariable-adjusted associations with resilience.ResultsOf 31 045 participants (18 672 [60%] women; 10 746 [34.6%] aged <65 years), 1185 (3.8%) identified as American Indian, 6728 (21.7%) as Black, 293 (0.9%) as East Asian, 6311 (20.3%) as Hispanic, 565 (1.8%) as South Asian, and 15 961 (51.3%) as White; a total of 23 103 participants (74.4%) self-identified as resilient. Compared with White participants, Black and Hispanic participants had higher prevalence of self-reported resilience (adjusted PR [aPR], 1.04; 95% CI, 1.02-1.06; aPR, 1.08; 95% CI, 1.06-1.11; respectively) and American Indian and East Asian participants had lower prevalence (aPR, 0.90; 95% CI, 0.86-0.94; aPR, 0.76; 95% CI, 0.68-0.84; respectively). Higher education, being married or living as married, higher income, and overweight were also associated with higher prevalence of resilience. Being female, having diabetes, and being unemployed were associated with lower prevalence of self-reported resilience. Compared with participants with public insurance only, participants with private insurance had higher prevalence of resilience (aPR, 1.07; 95% CI, 1.03-1.10). COVID-19 vaccination and infection statuses were not significantly associated with resilience. Modification analyses showed important racial and ethnic differences in how factors such as hypertension, marital status, and insurance status were associated with resilience.Conclusions and RelevanceIn this cross-sectional study of 31 045 adults, self-reported resilience varied by race, ethnicity, and sociodemographic factors. These findings highlight the complex interplay of individual and social factors in shaping the perception of resilience.
Longitudinal Clinical Course of Participants With Asthma in Severe Asthma Research Program (SARP) Cohort
Phillips, Brenda R. , Gauthier, M., Israel, Elliot , Mauger, David T. , Ortega, Victor E. , Zein, Joe , Bleecker, Eugene R., Aronica, M.A., Comhair, Suzy , Denlinger, Loren C. , Erzurum, Serpil C. , Jarjour, Nizar N. , Moore, Wendy C. , Woodruff, Prescott G. , Sumino, Kaharu , Gauthier, M., Townsend, E.A., Castro, Mario , Fahy, John V. , Levy, Bruce David , Phipatanakul, Wanda , Wenzel, Sally E.

C102. CLINICAL AND TRANSLATIONAL ADVANCES IN ASTHMA | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A6697-A6697

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a6697 Get It

Association of Smoking History With COVID-19 Infection, Hospitalization and Death in the C4R Study
Bowler, R.P., Elkind, Mitchell S, Kaplan, Ronald, Lee, J.S., Ortega, Victor E. , Ramachandran, V., Woodruff, Prescott G. , Balte, Pallavi , Allen, Norrina B. , Barr, R. Graham , Bowler, R.P., Cole, Shelley A. , Couper, David , Cushman, Mary , Demmer, Ryan T. , Doyle, Margaret F. , Howard, Virginia J. , Kanaya, Alka M , Kaplan, R., Phipatanakul, Wanda , Post, Wendy S. , Ramachandran, V., Schwartz, David A. , Tracy, Russell P. , Wenzel, Sally E. , Xanthakis, Vanessa , Oelsner, Elizabeth C.

B14. COVID SEVERITY, OUTCOMES, AND DISPARITIES: FROM MOLECULE TO COMMUNITY | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A2752-A2752

10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2752 Get It